acetylglucosamine has been researched along with dinaciclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Shibuya, H; Shimizu, M; Tanaka, N | 1 |
1 other study(ies) available for acetylglucosamine and dinaciclib
Article | Year |
---|---|
Enhanced O-GlcNAc modification induced by the RAS/MAPK/CDK1 pathway is required for SOX2 protein expression and generation of cancer stem cells.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Carcinogenesis; CDC2 Protein Kinase; Cyclic N-Oxides; Enzyme Inhibitors; Gene Expression; Humans; Indolizines; Mice; Mitogen-Activated Protein Kinases; Neoplastic Stem Cells; Pyridinium Compounds; ras Proteins; Signal Transduction; SOXB1 Transcription Factors | 2022 |